Skip navigation
Ivermectin + Mebendazole: The Cancer Study That Changes the Conversation.
0:00 / 1:50

Ivermectin + Mebendazole: The Cancer Study That Changes the Conversation.

McCullough Foundation

@McCulloughFund79K followers

Visit on X
713 likesDownloadOriginal post

15,967 views

Ivermectin + Mebendazole: The Cancer Study That Changes the Conversation. Two anti-infective drugs. Both already FDA-approved. Both already widely available. Together they reduce cancer cell proliferation, cut off the tumor's blood supply, and trigger cancer cell self-termination. 84% net clinical benefit across prostate, breast, and lung cancer patients. The National Cancer Institute needs to move on this now. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), American Sunrise #MedicalFreedom

12 Comments

Comments from the original post on X (Twitter)

  • Ogre in My Swamp's profile picture

    @idummkopp

    What’s being presented here is not a “breakthrough” — it’s a misrepresentation of early-stage research dressed up as clinical fact. First, “FDA-approved” is being misused. Yes, ivermectin and mebendazole are approved — but only for parasitic infections, not for cancer. Approval in one area does not imply effectiveness in another. Second, the claims about “cutting off blood supply” or “triggering self-termination of cancer cells” come from laboratory or animal studies, not real-world patient outcomes. Countless substances show anti-cancer effects in petri dishes — almost none translate into effective human treatments. Third, the “84% clinical benefit” claim is simply not credible. There is no robust, large-scale clinical trial demonstrating anything close to that across prostate, breast, and lung cancer. If such results existed, this would already be global standard treatment, not a social media post. Fourth, the suggestion that institutions like the National Cancer Institute are ignoring this is misleading. These compounds have been studied where relevant — and the evidence so far is weak, inconsistent, or insufficient for clinical use. Finally, the source matters. This narrative follows the same pattern seen before: take preliminary or low-quality data exaggerate the findings present them as suppressed “truth” That is not how science works. Bottom line: There is no credible clinical evidence that ivermectin + mebendazole provide meaningful cancer treatment benefit. What you’re seeing here is false hope built on distortion, not data.

    3 likes

  • Tokyogreen's profile picture

    @Tokyogreen

    What a load of desperate DRIVEL 😂 The McCullough Foundation constantly has its "studies" retracted. Here's an explanation.

    2 likes

  • SJG351's profile picture

    @sjg351

    @resilient333 Dr William Makis has over 9000 cancer patients using IVM combinations, fantastic success stories.

    2 likes

  • Daily Story's profile picture

    @DailyStory_xyz

    This study is a game changer for cancer treatment! Both drugs being FDA-approved is a huge advantage

  • karen's profile picture

    @kjch

    Wonderful.

  • Taylor Tolliver's profile picture

    @taylortolliver

    They’re not anti infectives. That would make them an anti biotic. Theyre anti parasitic

  • 36CIA(💕紫游)'s profile picture

    @36_cia7

    @GaillardThierr4 I hope Americans won’t dig out your ancestors grave soon How many days left for you?

  • José Larez's profile picture

    @JosLarez710928

    Cómo dar ivermectina más mebendazol

  • Rich Lives Matter's profile picture

    @MatterRichLives

    Safe and ineffective

  • Kurt Butler's profile picture

    @MauiLiberty

    Has he provided info on clinical trials that prove his contention?

  • Richie Pepperfield's profile picture

    @Pepperfield87

    I found a parasite-cleanse protocol(Ivm,fenben,Activated charcoal) from @HeatherWills_MD here on X and followed her guidance,after three months, I had improved mental clarity and clearer skin,the results were impressive. She’s trustworthy and really the best.

  • FX6353775's profile picture

    @FX6353775

    Ivermectin is cardiotoxic.